. "2011-08-08+02:00"^^ . "http://www.isvav.cz/projectDetail.do?rowId=NS10387"^^ . . . "free light chains; monoclonal gammopathy of unkno; multiple myeloma"@en . . "free light chains" . "Stanoven\u00ED voln\u00FDch lehk\u00FDch \u0159et\u011Bzc\u016F jako pomocn\u00E9ho markeru v hodnocen\u00ED progn\u00F3zy a odpov\u011Bdi na l\u00E9\u010Dbu u nemocn\u00FDch s mnoho\u010Detn\u00FDm myelomem a monoklon\u00E1ln\u00ED gamapati\u00ED nejasn\u00E9ho v\u00FDznamu" . . "1"^^ . . . "1"^^ . "projekt se sna\u017Eil vyu\u017E\u00EDt stanoven\u00ED voln\u00FDch lehk\u00FDch \u0159et\u011Bzc\u016F v seru jako ukazatele n diagnostice MGUS"@cs . . " monoclonal gammopathy of unkno" . "2009-01-01+01:00"^^ . "Project was focused on verifying of the usefulness of free light chain analysis as a new marker in diagnosis of MGUS"@en . "0"^^ . . . . . "NS10387" . "Mo\u017Enosti v\u00FDvoje nov\u00FDch metod ke stanoven\u00ED FLC - optimalizace m\u011B\u0159en\u00ED technikou ELISA a porovn\u00E1n\u00ED s metodou st\u00E1vaj\u00EDc\u00ED. Stanoven\u00ED FLC jako markeru stringer CR u mnoho\u010Detn\u00E9ho myelomu, ujasn\u011Bn\u00ED v\u00FDznamu sCR ve vztahu k progn\u00F3ze. Anal\u00FDza FLC jako ukazatele progn\u00F3zy u monoklon\u00E1ln\u00ED gamapatie nejasn\u00E9ho v\u00FDznamu. Vyu\u017Eit\u00ED FLC pro \u010Dasnou predikci rezistence na drah\u00E9 l\u00E9ky s c\u00EDlem ekonomick\u00E9ho p\u0159\u00EDstupu k l\u00E9\u010Db\u011B." . "2013-10-31+01:00"^^ . . . . "2011-12-31+01:00"^^ . . "42"^^ . "Assessment of free light chains as auxiliary marker for the evaluation of prognosis and of the response to treatment in patients with multiple myeloma and with monoclonal gammopathy of unknown significance"@en . "42"^^ . "Development possibilities of new methods for FLC assay \u2013 measurement optimization via ELISA instruments and comparison with the current method. Determination of FLC as a marker of the stringent CR in multiple myeloma, realization of the sCR importance in relation to prognosis. FLC analysis as the prognosis indicators in monoclonal gammopathy of undetermined significance. Use of FLC for early prediction of resistance to expensive medicaments aimed at economic approach to the treatment."@en . . .